Condition (MeSH)
Arthrogryposis
ClinicalTrials.gov lists 16 trials for Arthrogryposis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
16 of the 16 trials are tagged with Arthrogryposis itself; the rest are tagged with a narrower condition beneath it.
When did Arthrogryposis trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2024 | 1 |
| 2022 | 2 |
| 2021 | 1 |
| 2020 | 1 |
| 2019 | 2 |
| 2014 | 3 |
| 2011 | 1 |
| 2010 | 1 |
| 2008 | 1 |
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Arthrogryposis trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Not applicable | 5 |
| Observational | 10 |
How many Arthrogryposis trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Completed | 5 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Arthrogryposis? (25)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Findings, Phenotypes, Diagnostic Accuracy, and Treatment in Freeman-Burian Syndrome. | The Journal of craniofacial surgery | 2020 | Yes |
| Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis. | Human mutation | 2019 | Yes |
| International multidisciplinary collaboration toward an annotated definition of arthrogryposis multiplex congenita. | American journal of medical genetics. Part C, Seminars in medical genetics | 2019 | Yes |
| The diagnostic workup in a patient with AMC: Overview of the clinical evaluation and paraclinical analyses with review of the literature. | American journal of medical genetics. Part C, Seminars in medical genetics | 2019 | Yes |
| Disability in adults with arthrogryposis is severe, partly invisible, and varies by genotype. | Neurology | 2018 | Yes |
Showing 5 of 25 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Arthrogryposis syndrome | 109007 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Arthrogryposis syndrome | 109007 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, drugs tested, serious adverse events in this condition's trials, prevalence, and sub-conditions in mesh.